Clomifene Citrate IP + Ubidecarenone(Coenzyme Q10) Tablet

Clomifene Citrate IP + Ubidecarenone(Coenzyme Q10) Tablet comes with the branding “Orinest CQ” and is a medication used to help women who have trouble getting pregnant because they aren’t ovulating regularly. It combines Clomifene Citrate, which helps increase hormone levels needed for ovulation, with Ubidecarenone, an antioxidant that protects the body from harmful chemicals that can affect fertility. By using this combination, it effectively treats female infertility caused by ovulation issues.

Medical Benefits

• Clomifene Citrate boosts hormone production for ovulation.
• Ubidecarenone acts as an antioxidant, protecting against chemicals that affect fertility and helps to improve response to ovulation treatment.
• Reduces the risk of abnormal chromosome count in the fetus.
• Effectively treats female infertility by addressing ovulation issues and promoting a healthier reproductive environment.

Dirеctions For Usе

• It is rеcommеndеd to swallow Clomifene Citrate IP + Ubidecarenone(Coenzyme Q10) Tablet wholе with a liquid, prеfеrably aftеr mеals.
• Rеad and follow thе instructions providеd on thе this tablеt labеl.
• Do not crush, brеak, or chеw this mеdicinе.

Storagе

• Be surе that the tablеt is out of rеach of childrеn.
• Protect it by keeping the medicine in a cool, dry place.
• Avoid keeping Clomifene Citrate IP + Ubidecarenone(Coenzyme Q10) Tablet from sunlight.

Precautions

• Talk to your doctor before taking this medicine as it may interact with an anti-cancer agent (e.g. bexarotene) and blood thinners (e.g. warfarin, dicumarol, anisindione).
• Alcohol may increase the risk of side effects of Clomifene Citrate IP + Ubidecarenone(Coenzyme Q10) Tablet.
• This medicine is a category X drug and is not recommended to be taken in pregnancy as this tablet may cause birth defects/congenital disabilities in the unborn baby.
• It may interact with disease conditions, including abnormal uterine bleeding, liver failure, hyperlipidemia (increased fat levels), uncontrolled adrenal gland dysfunction, thyroid problems, and pituitary tumors.
• This medicine decreases the supply of breast milk. Thus, consult your doctor before taking this medicine if you are breastfeeding.

Side Effects

• Headache
• Flushing
• Dizziness
• Breast pain or tenderness
• Tiredness

Contact ISO Certified Clomifene Citrate IP + Ubidecarenone(Coenzyme Q10) Tablet Manufacturer and Supplier in India

Under the leadership of Mr. Rahul Marwaha (CEO), Somcare is a leading third-party manufacturing company for Clomifene Citrate IP + Ubidecarenone(Coenzyme Q10) Tablet at budget-friendly prices. The company offers more than 70 products with safe Packaging, accurate composition, effectiveness, and long shelf life. Our team focuses on quality and quantity to develop effective products without any risk of side effects. The company built a reputed position in the pharma industry by providing a wide range of pharma drugs. Somacare also offers a Best PCD Pharma Franchise for Clomifene Citrate IP + Ubidecarenone(Coenzyme Q10) Tablet in India.

• We Regularly check and clean the fixed machinery.
• Well-supervised by a talented team of experts.
• Maintain a hygienic environment in our firm.
• on-time delivery of demanding products.

Frequently Asked Questions (FAQs)

Why am I not getting pregnant after taking this medicine?

It can enhance fertility, but failure to conceive may be due to factors such as low dosage, underlying causes of infertility, or other conditions affecting its effectiveness. Consulting a doctor is advised to determine the exact reason.

How does this composition increase the possibility of multiple pregnancies?

It stimulates egg development in the ovaries, potentially leading to the release of multiple eggs during ovulation. This increases the likelihood of conceiving twins, triplets, or more.

When is the ideal time to try to conceive after using this tablet?

Ovulation typically occurs 7 to 10 days after the last dose of it. To maximize chances of conception, it’s recommended to have intercourse daily or every other day from Day 11 through Day 21 of the menstrual cycle.